In general, cancer biomarkers are classified by their different functions; biomarkers that trigger cells to grow and multiply abnormally; biomarkers that support a treatment’s cellular or molecular action; and biomarkers that disrupt a treatment’s cellular or molecular action.Regulatory affairs play critical roles throughout the lifecycle of pharmaceuticals, medical devices, biologics, veterinary medicines, pesticides, agrochemicals, cosmetics and complementary medicine and functional foods.Anti-bacterials are the largest segment of the anti-infectives market and within this segment, drugs for resistant bacteria are of most concern.The ultimate solution to anti-infective drug resistance is prevention of infection through vaccination, and continued research and development of vaccines is an important part of any strategy to address drug resistance.Gene-based and cellular biologics, for example, are often at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available.Biomarkers have many potential applications in oncology, including risk assessment, screening, differential diagnosis, determination of prognosis, prediction of response to treatment and monitoring of progression of the disease.Targeted drug delivery systems can directly deliver the payload to the desired site of action without undesired interaction with normal cells. use of microfluidics, nanoparticle-based formulations, and use of monoclonal antibodies for anticancer drugs are in the market and many more are in research phase.
Cardiovascular disorders are the predominant cause of death or disability in the industrialized world and increasingly prevalent in developing nations.
Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer.
They can be found in the blood, stool, urine, tumor tissue, or other tissues and bodily fluids.
This international conference organized by Eureka Science is unique in bringing state-of-the-art in the fields of drug discovery and therapy closer to the doorstep of pharmaceutical scientists, internists and primary care physicians from all over the world.
The event is scheduled to be held at the United Nations Conference Centre (UNCC), in Bangkok, Thailand.